Latest Ratios: P/E Ratio -1.0x · EV/EBITDA N/A · ROE -28.9%. (2018–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $124M | $137M | $169M | $323M | $261M | $504M | $2.0B | — | — |
| Enterprise Value | $161M | $174M | $221M | $381M | $307M | $456M | $1.9B | — | — |
| P/E Ratio → | -1.00 | — | — | — | — | — | — | — | — |
| P/S Ratio | — | — | — | — | — | — | — | — | — |
| P/B Ratio | 0.41 | 0.44 | 0.41 | 1.18 | 0.70 | 2.01 | 6.08 | — | — |
| P/FCF | — | — | — | — | — | — | — | — | — |
| P/OCF | — | — | — | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | — | — | — | — | — | — | — | — |
| EV / EBITDA | — | — | — | — | — | — | — | — | — |
| EV / EBIT | — | — | — | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | — | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | — | — | — | — | — | — | — | 85.1% | 35.1% |
| Operating Margin | — | — | — | — | — | — | — | -19368.7% | -5.4% |
| Net Profit Margin | — | — | — | — | — | — | — | -18265.7% | -4.2% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| ROE | -28.9% | -28.9% | -31.9% | -36.4% | -36.5% | -30.1% | -61.8% | — | — |
| ROA | -23.0% | -23.0% | -24.7% | -27.6% | -30.5% | -28.1% | -47.3% | -72.7% | -2.9% |
| ROIC | -22.5% | -22.5% | -24.3% | -26.4% | -28.8% | -29.7% | -39.7% | — | — |
| ROCE | -28.0% | -28.0% | -30.6% | -32.6% | -33.4% | -29.3% | -27.9% | -93.6% | -4.7% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.24 | 0.24 | 0.20 | 0.32 | 0.22 | 0.05 | 0.03 | — | — |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — |
| Net Debt / Equity | — | 0.12 | 0.13 | 0.21 | 0.12 | -0.19 | -0.27 | — | — |
| Net Debt / EBITDA | — | — | — | — | — | — | — | — | — |
| Debt / FCF | — | — | — | — | — | — | — | — | — |
| Interest Coverage | — | — | — | — | -19.37 | — | — | -43.56 | — |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 12.69 | 12.69 | 14.45 | 10.85 | 16.36 | 18.99 | 36.10 | 4.56 | 3.96 |
| Quick Ratio | 12.69 | 12.69 | 14.45 | 10.85 | 16.36 | 18.99 | 36.10 | 4.56 | 3.91 |
| Cash Ratio | 12.41 | 12.41 | 14.13 | 10.64 | 15.97 | 18.40 | 35.66 | 4.51 | 3.79 |
| Asset Turnover | — | — | — | — | — | — | — | 0.00 | 0.68 |
| Inventory Turnover | — | — | — | — | — | — | — | — | 36.25 |
| Days Sales Outstanding | — | — | — | — | — | — | — | — | 8.36 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — | — | — | — |
| FCF Yield | — | — | — | — | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | — |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | — |
| Shares Outstanding | — | $74M | $68M | $49M | $44M | $33M | $32M | $9M | $50M |
Includes 30+ ratios · 8 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying NKTX stock.
Nkarta, Inc.'s current P/E ratio is -1.0x. This places it at the 50th percentile of its historical range.
Nkarta, Inc.'s return on equity (ROE) is -28.9%. The historical average is -37.6%.
Based on historical data, Nkarta, Inc. is trading at a P/E of -1.0x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Key Metrics
Top Statement Risk
Cash runway against persistent burn
Metrics are mathematically derived from official filings.
Trading Below Book Reflects Burn Skepticism
At a P/B of 0.41 and negative trailing P/E of -1.23, NKTX trades well below book value, which according to reported figures suggests the market discounts the equity base heavily against ongoing losses.
A price-to-book ratio of 0.41 means investors are paying roughly 41 cents for each dollar of reported equity, which, given equity has fallen to $247.7M from $473.7M over two years, points to market skepticism about how much of that book value can be converted into shareholder returns. The negative P/E is not meaningful as a valuation signal on its own, since earnings are negative and the multiple carries no information about growth expectations. Investors should monitor whether book value per share continues to erode faster than the share price adjusts, as this would indicate the discount is tracking balance sheet depletion rather than temporary mispricing.
Returns Deteriorating Alongside Widening Losses
ROE has moved from -5.4% in 2024Q2 to -15.1% in 2026Q2 and ROIC to -10.3%, based on reported quarterly figures, indicating return erosion that has accelerated in the most recent periods.
The decline in ROE to -15.1% in the latest quarter reflects both a widening net loss and a shrinking equity denominator, meaning the ratio deteriorates through two channels at once. ROIC at -10.3% versus -5.8% in 2024Q3 shows that invested capital is not generating a return even before considering the cost of capital. Because the company has no revenue base, these returns cannot be decomposed into margin and efficiency drivers, so the analysis relies entirely on the trajectory of losses against a contracting capital base.
Low Debt Ratio Masks Cash Dependence
The debt-to-equity ratio has risen from 0.18 to 0.30 while cash fell to $25.0M, according to reported figures, so the modest leverage figure may understate near-term funding pressure.
A debt-to-equity ratio of 0.30 appears conservative in isolation, but the rise from 0.18 reflects equity shrinking faster than borrowings, which is the direction a lender or investor would monitor. Interest coverage and debt-to-EBITDA cannot be computed because operating earnings are negative, so the usual covenant tests are unavailable. The more material vulnerability is that cash of $25.0M against quarterly operating burn that has reached roughly $30M suggests the company's ability to service obligations depends on external financing rather than internal cash generation.
Elevated Current Ratio Obscures Thin Cash
A current ratio of 7.98 in 2026Q2 looks strong, yet cash of $25.0M against burn near $30M per quarter, based on reported figures, implies limited months of runway.
The current ratio fell from 19.95 in 2024Q1 to 7.98 in 2026Q2, a steep decline that reflects cash depletion rather than any improvement in working capital quality. Current liabilities are small relative to assets, so the ratio mostly reflects the composition of a shrinking asset base dominated by cash and short-term holdings. Under stress, the relevant question is not the ratio but whether cash reserves can fund the next several quarters of operating outflows without new capital, which warrants further investigation given the recent pace of decline.
Low Book Multiple Could Mislead on Value
Because the P/B of 0.41 is applied to an equity base that is itself being consumed by losses, based on reported figures, a low price-to-book ratio may signal value trap risk rather than undervaluation.
P/B is commonly read as a margin of safety, but for a cash-burning biotech the book value is a depleting asset, so a multiple below one can persist or widen as equity is spent down. A more relevant adjustment is to compare market capitalization against cash and near-term burn, which shows how many quarters of runway the current price implicitly prices in. Investors should treat the low P/B as a prompt to test the sustainability of the balance sheet rather than as evidence the shares are cheap.